Insider Transactions in Q3 2021 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2021
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
9,548
-1.93%
|
$47,740
$5.46 P/Share
|
|
Aug 26
2021
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+6.3%
|
$49,998
$3.12 P/Share
|
|
Aug 25
2021
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
80,000
-9.74%
|
$400,000
$5.56 P/Share
|
|
Aug 25
2021
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
120,000
+12.74%
|
$360,000
$3.12 P/Share
|
|
Aug 25
2021
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
9,498
-3.95%
|
$47,490
$5.56 P/Share
|
|
Aug 25
2021
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+6.48%
|
$50,001
$3.12 P/Share
|
|
Aug 24
2021
|
Philip H Coelho Director |
SELL
Open market or private sale
|
Direct |
9,494
-4.07%
|
$47,470
$5.58 P/Share
|
|
Aug 24
2021
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+6.66%
|
$50,001
$3.12 P/Share
|
|
Aug 23
2021
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
82,617
-1.65%
|
$413,085
$5.62 P/Share
|
|
Aug 23
2021
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
120,000
+2.35%
|
$360,000
$3.12 P/Share
|
|
Aug 20
2021
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
54,161
-1.1%
|
$270,805
$5.52 P/Share
|
|
Aug 20
2021
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+1.6%
|
$240,000
$3.12 P/Share
|
|
Aug 18
2021
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
13,000
-2.72%
|
$65,000
$5.68 P/Share
|
|
Aug 18
2021
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+12.79%
|
$210,000
$3.12 P/Share
|
|
Aug 17
2021
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
100,000
-19.71%
|
$500,000
$5.67 P/Share
|
|
Aug 17
2021
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+16.46%
|
$300,000
$3.12 P/Share
|
|
Aug 16
2021
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.56%
|
$150,000
$3.12 P/Share
|
|
Aug 13
2021
|
David S Tierney Director |
SELL
Open market or private sale
|
Direct |
50,000
-14.01%
|
$300,000
$6.08 P/Share
|
|
Aug 13
2021
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+12.29%
|
$150,000
$3.12 P/Share
|
|
Aug 13
2021
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
40,963
-5.52%
|
$245,778
$6.09 P/Share
|
|
Aug 13
2021
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+8.05%
|
$195,000
$3.12 P/Share
|
|
Aug 13
2021
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
62,715
-0.64%
|
$376,290
$6.12 P/Share
|
|
Aug 13
2021
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+2.0%
|
$300,000
$3.12 P/Share
|